| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |